Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079482 · ClinicalTrials.gov registry record · Phase 2
Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
A Phase 2 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 2
- Development phase
- 224
- Enrollment target
NCT00079482: Completed Phase 2 study, sponsored by Cephalon.
NCT00079482 is a Phase 2 study that has completed, run by Cephalon. The registered enrollment target is 224 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00079482, a Phase 2 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 224 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether CEP-701 given in sequence with induction chemotherapy increases the proportion of patients with relapsed acute myeloid leukemia (AML) who achieve a second complete remission (CR).
Interventions
- DRUG CEP-701
- DRUG high-dose cytarabine
- DRUG Mitozantrone, Etoposide, Cytarabine (combination Chemotherapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2003-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 2 |
What the finished NCT00079482 record still lists
NCT00079482 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher).
The record links to 0 conditions, and to 3 interventions - of which CEP-701 is the first listed.
NCT00079482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00079482 about?
NCT00079482 is a clinical study titled "Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)". The purpose of the study is to determine whether CEP-701 given in sequence with induction chemotherapy increases the proportion of patients with relapsed acute myeloid leukemia (AML) who achieve a second complete remission (CR).
What is the current status of trial NCT00079482?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 224 participants. The study started on 2003-10. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00079482?
The interventions under investigation include: CEP-701 (DRUG), high-dose cytarabine (DRUG), Mitozantrone, Etoposide, Cytarabine (combination Chemotherapy) (DRUG).
Who is sponsoring clinical trial NCT00079482?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00079482's enrollment target sits among peer trials
224 269th of 2000 higher than 1,727 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia